- Home
- FONR vs FATE Comparison
FONR vs FATE Comparison
Compare FONR & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FONR | FATE |
|---|---|---|
| Founded | 1978 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.8M | 125.6M |
| IPO Year | 1995 | 2013 |
Fundamental Metrics
Financial Performance| Metric | FONR | FATE |
|---|---|---|
| Price | $18.62 | $1.18 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.10 |
| AVG Volume (30 Days) | 43.1K | ★ 1.3M |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.88 |
| EPS | ★ 1.16 | N/A |
| Revenue | ★ $104,351,318.00 | $6,646,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $16.02 | ★ N/A |
| Revenue Growth | ★ 1.43 | N/A |
| 52 Week Low | $12.00 | $0.86 |
| 52 Week High | $18.86 | $1.94 |
Technical Indicators
Market Signals| Indicator | FONR | FATE |
|---|---|---|
| Relative Strength Index (RSI) | 61.18 | 47.67 |
| Support Level | $18.49 | $1.06 |
| Resistance Level | $18.63 | $1.30 |
| Average True Range (ATR) | 0.06 | 0.08 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 98.39 | 53.70 |
Price Performance
Historical ComparisonAbout FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.